Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Evaluation of a type 1 diabetes serum cohort by SELDI-TOF MS protein profiling.

Albrethsen J, Kaas A, Schönle E, Swift P, Kocova M, Gammeltoft S, Hansen L, Mortensen HB.

Proteomics Clin Appl. 2009 Mar;3(3):383-93. doi: 10.1002/prca.200800063.

PMID:
22275309
3.

SELDI-TOF-MS of saliva: methodology and pre-treatment effects.

Schipper R, Loof A, de Groot J, Harthoorn L, Dransfield E, van Heerde W.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Feb 15;847(1):45-53. Epub 2006 Oct 27.

PMID:
17070117
4.

Time course proteomic profiling of human myocardial infarction plasma samples: an approach to new biomarker discovery.

Silbiger VN, Luchessi AD, Hirata RD, Neto LG, Pastorelli CP, Ueda EK, dos Santos ES, Pereira MP, Ramos R, Sampaio MF, Armaganijan D, Paik SH, Murata Y, Ooi GT, Ferguson EW, Hirata MH.

Clin Chim Acta. 2011 May 12;412(11-12):1086-93. doi: 10.1016/j.cca.2011.02.030. Epub 2011 Feb 26.

6.
7.

Proteomic identification of serum biomarkers for head and neck cancer surveillance.

Gourin CG, Zhi W, Adam BL.

Laryngoscope. 2009 Jul;119(7):1291-302. doi: 10.1002/lary.20279.

PMID:
19444892
8.

SELDI-TOF MS profiling of serum for detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis.

Cheng L, Zhou L, Tao L, Zhang M, Cui J, Li Y.

J Cancer Res Clin Oncol. 2008 Jul;134(7):769-76. doi: 10.1007/s00432-007-0344-4. Epub 2008 Jan 17.

PMID:
18202856
9.

The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification.

Issaq HJ, Veenstra TD, Conrads TP, Felschow D.

Biochem Biophys Res Commun. 2002 Apr 5;292(3):587-92.

PMID:
11922607
10.
11.

Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF.

Gretzer MB, Chan DW, van Rootselaar CL, Rosenzweig JM, Dalrymple S, Mangold LA, Partin AW, Veltri RW.

Prostate. 2004 Sep 1;60(4):325-31.

PMID:
15264244
12.

Proteomic profiling of renal allograft rejection in serum using magnetic bead-based sample fractionation and MALDI-TOF MS.

Sui W, Huang L, Dai Y, Chen J, Yan Q, Huang H.

Clin Exp Med. 2010 Dec;10(4):259-68. doi: 10.1007/s10238-010-0094-5. Epub 2010 Apr 8.

PMID:
20376689
13.

Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis.

de Seny D, Fillet M, Ribbens C, Marée R, Meuwis MA, Lutteri L, Chapelle JP, Wehenkel L, Louis E, Merville MP, Malaise M.

Clin Chem. 2008 Jun;54(6):1066-75. doi: 10.1373/clinchem.2007.099549. Epub 2008 Apr 24.

14.

Proteomic profiling of ovine serum by SELDI-TOF MS: optimisation, reproducibility and feasibility of biomarker discovery using routinely collected samples.

Zhong L, Taylor DL, Whittington RJ.

Comp Immunol Microbiol Infect Dis. 2010 Jan;33(1):47-63. doi: 10.1016/j.cimid.2008.07.009. Epub 2008 Sep 4.

PMID:
18775566
15.

Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.

Zinkin NT, Grall F, Bhaskar K, Otu HH, Spentzos D, Kalmowitz B, Wells M, Guerrero M, Asara JM, Libermann TA, Afdhal NH.

Clin Cancer Res. 2008 Jan 15;14(2):470-7. doi: 10.1158/1078-0432.CCR-07-0586.

16.

Surface-enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS): a new proteomic urinary test for patients with urolithiasis.

Cadieux PA, Beiko DT, Watterson JD, Burton JP, Howard JC, Knudsen BE, Gan BS, McCormick JK, Chambers AF, Denstedt JD, Reid G.

J Clin Lab Anal. 2004;18(3):170-5.

PMID:
15103681
17.

Application of serum SELDI proteomic patterns in diagnosis of lung cancer.

Yang SY, Xiao XY, Zhang WG, Zhang LJ, Zhang W, Zhou B, Chen G, He DC.

BMC Cancer. 2005 Jul 20;5:83.

18.

Derivatized cellulose combined with MALDI-TOF MS: a new tool for serum protein profiling.

Feuerstein I, Rainer M, Bernardo K, Stecher G, Huck CW, Kofler K, Pelzer A, Horninger W, Klocker H, Bartsch G, Bonn GK.

J Proteome Res. 2005 Nov-Dec;4(6):2320-6.

PMID:
16335981
19.

Proteomic analysis of archival breast cancer serum.

Zeidan BA, Cutress RI, Murray N, Coulton GR, Hastie C, Packham G, Townsend PA.

Cancer Genomics Proteomics. 2009 May-Jun;6(3):141-7.

20.

Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).

O'Gorman D, Howard JC, Varallo VM, Cadieux P, Bowley E, McLean K, Pak BJ, Gan BS.

Clin Invest Med. 2006 Jun;29(3):136-45.

PMID:
17058431

Supplemental Content

Support Center